1.71
Schlusskurs vom Vortag:
$1.66
Offen:
$1.64
24-Stunden-Volumen:
556.31K
Relative Volume:
2.50
Marktkapitalisierung:
$102.23M
Einnahmen:
$14.18M
Nettoeinkommen (Verlust:
$-82.66M
KGV:
-1.3154
EPS:
-1.3
Netto-Cashflow:
$-50.80M
1W Leistung:
-1.72%
1M Leistung:
-16.18%
6M Leistung:
-14.50%
1J Leistung:
-0.58%
Seer Inc Stock (SEER) Company Profile
Firmenname
Seer Inc
Sektor
Branche
Telefon
650-453-0000
Adresse
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Vergleichen Sie SEER mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SEER
Seer Inc
|
1.71 | 102.23M | 14.18M | -82.66M | -50.80M | -1.30 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Seer Inc Stock (SEER) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
2023-01-04 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-08-11 | Herabstufung | JP Morgan | Overweight → Neutral |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2020-12-29 | Eingeleitet | BofA Securities | Neutral |
2020-12-29 | Eingeleitet | Cowen | Outperform |
2020-12-29 | Eingeleitet | JP Morgan | Overweight |
2020-12-29 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Seer Inc Aktie (SEER) Neueste Nachrichten
Seer : Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - MarketScreener
Corient Private Wealth LLC Acquires 13,200 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED - GlobeNewswire
New Carbon Credit Powerhouse: SEER Unveils 60-Kiln Biochar Facility with $176 Per Credit Value - Stock Titan
After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - MSN
After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - Yahoo Finance
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates - MSN
Large Tools and Labs Optimistic at TD Cowen Health Conference By Investing.com - Investing.com Australia
Large Tools and Labs Optimistic at TD Cowen Health Conference - Investing.com India
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look Fo - GuruFocus.com
SEER, INC. : Results of Operations and Financial Condition (form 8-K) -January 25, 2021 at 04:40 pm EST - MarketScreener
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround - Yahoo Finance
Y Intercept Hong Kong Ltd Acquires New Shares in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook - TipRanks
Seer, Inc. SEC 10-K Report - TradingView
Seer Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance
Teams at Neptune Beach's Fletcher High win spots at national investment competition - MSN
Seer, Inc. (NASDAQ:SEER) Q4 2024 Earnings Call Transcript - Insider Monkey
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Rev - GuruFocus.com
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... - Yahoo Finance
Seer, Inc. Reports 2024 Earnings and 2025 Outlook - TipRanks
Seer Inc (SEER) Q4 2024 Earnings: Revenue Beats at $4.0M, EPS Mi - GuruFocus.com
Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Seer Inc. reports Q4 2024 revenue decline, stock rises - Investing.com
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook - The Manila Times
Can Seer's New Proteomics Application Drive Its Ambitious 24% Revenue Growth Target? - StockTitan
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025 - Technology Networks
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Seer Inc. (SEER) Earnings Preview: Q4 2024 Revenue Expected to Decline 11% - HPBL
Monash University's Proteomics & Metabolomics Platform Strengthens Partnerships with Seer and Thermo Fisher Scientific - Monash University
Seer to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Seer's Proteomics Platform Disrupt Healthcare? Management Reveals Strategy Next Week - StockTitan
Seer (SEER) Expected to Announce Quarterly Earnings on Thursday - Defense World
Seer to Feature Proteomic Advancements in Cancer and RNA - GlobeNewswire
US Penny Stocks: 3 Picks With Market Caps As Low As $70M - Simply Wall St
Seer, Inc. to Showcase Innovations in Proteomics at US HUPO 2025 Annual Conference - Nasdaq
Revolutionary Cancer Therapy Platform: How Seer's Proteomics Technology is Reshaping Treatment Research - StockTitan
Peapod Lane Capital LLC Invests $991,000 in Seer, Inc. (NASDAQ:SEER) - MarketBeat
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire
Seer Proteomics Q4 Earnings Alert: Key Financial Metrics Unveiling February 27 - Stock Titan
Global X MSCI SuperDividend EAFE ETF (NASDAQ:EFAS) Shares Down 1.1% – What’s Next? - Armenian Reporter
Omid Farokhzad Sells 8,068 Shares of Seer, Inc. (NASDAQ:SEER) Stock - Armenian Reporter
Citrine Capital LLC Buys Shares of 24,875 Dimensional U.S. Equity ETF (NYSEARCA:DFUS) - Armenian Reporter
CSX Co. (NASDAQ:CSX) Shares Acquired by Glassy Mountain Advisors Inc. - Armenian Reporter
Sompo (OTCMKTS:SMPNY) Reaches New 1-Year High – Should You Buy? - Armenian Reporter
Illumina (ILMN) Q4 Earnings Miss Estimates - Yahoo Finance
Seer CEO Omid Farokhzad sells $18,044 in stock - MSN
Finanzdaten der Seer Inc-Aktie (SEER)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):